Fri, Oct 31, 2014, 9:02 AM EDT - U.S. Markets open in 28 mins.


% | $
Quotes you view appear here for quick access.

CollabRx, Inc. Message Board

  • green_side_up green_side_up Jan 18, 2013 11:20 AM Flag

    LIFE gains on takeover talk - CLRX - STRONG BUY now!

    Whether LIFE is public or private makes zero difference for CLRX. Everyone knows the medical industry is moving to personalized medicine. The opening of the human genome is creating new drug candidates that are increasingly protein / enzyme specific. As such, firms like Glaxo and Roche are co-developing or partnering on genetic tests that work with their drug targets. Thus, a test for a specific protein that is prevalent in a specific type of cancer will be given to those people who's DNA has that protein and drugs will be developed with that protein in mind. To sift through all of the hundreds of clinical trials and drug development that is exploding because of the human genome / personalized medicine, the need for both physician and patient to be aware of the drug trials, genetic tests, and highly specific drugs will become vitally important to patient care. CLRX is right smack in the middle of this phenomenon. And, LIFE sees this future, which is exactly why they partnered with CLRX and its vast medical knowledge network. That doesn't change if LIFE goes private. In fact, without the need to meet quarterly estimates, it's highly likely that LIFE accelerates its focus in this area.

    Oh, and by the way, CLRX is EXTREMELY cheap given its $1 billion + opportunity.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.75Oct 30 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.